Sign in

NCT04776291Completed

Correlation of Pre- and Post-operative Cancer Imaging Techniques

PET-PATH: Investigation of New Medical Imaging Techniques for Improving Lung Cancer Treatment

Source: ClinicalTrials.gov · Last updated 16 Apr 2025

Brief summary (registry, in English)

Various imaging modalities are used in medical diagnosis such as MRI, CT and PET. The images are sometimes acquired at different times and in different body positions, and thus need to be aligned for precise diagnosis and treatment planning. Different image modalities provide complementary information about the anatomical structure under study. Image registration techniques enable multimodality images to be projected onto a common coordinate system, so that these images can be aligned and spatial correspondences can be established between the images. This research project aims to investigate the information provided by functional PET and CT images about the tumour environment in lung cancer patients by registering functional PET and CT images with the pathology images acquired from the same patient. On identification of specific region of interest on the functional imaging the investigators will then be able to interrogate the tumour biology. In many cancers, the tumour environment is usually composed of a heterogeneous mass of tissue. The discrimination and classification of the carcinoma substructures is of paramount importance in the radiotherapy planning stage, as a given treatment may be more or less suitable depending on the local characteristics of the tumour. For instance, in hypoxic regions (areas inside the tumour with very low oxygen supply), radiotherapy performs poorly and strategies to intensify treatment to those areas could be investigated. This project will develop a framework for automatic registration of pathology images, which are taken from a surgically extracted lung tumour, with the corresponding PET/CT scan acquired from the patient before surgery. The registration of these images is essential for the evaluation of the performance of different PET radiotracers.

Status (registry)
Completed
Study type
Interventional
Enrollment
7 (actual)
First submitted
24 Feb 2021
Start date
15 Jun 2022
Primary completion date
1 May 2024
Lead sponsor
University of Strathclyde
Diseases
Lung cancer
NCT number
NCT04776291

What you commit to

  • Study type: Interventional
  • Participants enrolled: 7
  • From 15 Jun 2022 to the primary completion date, 1 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Patient is under 18 years old.

Who the study is looking for

  • Patient diagnosed with primary lung cancer and are due to undergo curative surgical resection of the tumour
  • At least one of the tumour's major axes is larger than 30mm.
  • The main volume of the tumour is located within the lung tissue.
  • Tumour is identified primarily as single mass lesion.

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
West of Scotland Pet Centre
Coordinator of this site? Confirm its status
GlasgowUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.